Patcharapit Promoppatum is the co-founder and CTO of OsseoLabs, a pioneering medical device startup specializing in advanced reconstructive procedures utilizing AI-powered technology and 3D printing. Recently expanding into the US market in 2024, with established partnerships in over 20 U.S. hospitals, OsseoLabs is positioned to meet the growing demand for specialized procedures, particularly in maxillofacial and orthopedic surgeries. With a focus on personalized surgical solutions, OsseoLabs' patented TPMS technology enables the creation of unique implants designed for optimal osseointegration, boasting significantly lower rejection rates compared to conventional methods. Actively pursuing FDA approval for the U.S. and European markets through a series A investment round, OsseoLabs aims to broaden its impact globally while adhering to a highly patient-centric approach, setting new standards in medical device innovation.